Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Sunscreen (SPF) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Prescription topical. Hydroquinone is used at 2-4% (often as the triple-combination with a retinoid and a mild corticosteroid), applied to pigmented areas usually at night, in time-limited courses (commonly with treatment breaks) under clinician supervision, always with daily sunscreen. There is no oral or systemic use. Avoid indefinite continuous use because of ochronosis risk. This library does not provide an ingestion protocol.
evening
Hydroquinone 2-4% cream or the triple-combination (with retinoid + mild steroid), under a clinician
Topical OTC. Apply a broad-spectrum SPF 30+ sunscreen daily to sun-exposed skin as the last step of a morning routine, using an adequate amount (about 2 mg/cm² — roughly a nickel-sized dollop for the face, a shot-glass for the body) and reapply every ~2 hours of sun exposure and after swimming/sweating. Mineral (zinc oxide / titanium dioxide) filters are preferred if you're concerned about systemic absorption. There is no oral or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
morning
Broad-spectrum SPF 30+, applied daily; mineral (zinc oxide/titanium dioxide) if concerned about absorption
Throughout
8-12 weeks
Throughout
Months to years
Throughout
Ongoing (years)
Ongoing
Throughout
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Cutis (2003) · Rct · n=641
Two pooled 8-week multicenter randomized investigator-blind trials (n=641) of the triple-combination (tretinoin 0.05% + hydroquinone 4% + fluocinolone 0.01%) vs the three dual pairings
Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial.
J Eur Acad Dermatol Venereol (2023) · Rct · n=40
24-week double-blind RCT (n=40) using Kligman's trio (hydroquinone + retinoic acid + corticosteroid) as the active gold-standard comparator
Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review.
J Am Acad Dermatol (2014) · Systematic review
Abridged Cochrane review of 20 RCTs (2125 participants) across 23 melasma treatments
Sunscreen and prevention of skin aging: a randomized trial.
Ann Intern Med (2013) · Rct · n=903
Randomized community trial (n=903): the daily sunscreen group showed no detectable increase in photoaging (skin microtopography) after 4.5 years
Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo.
J Investig Dermatol Symp Proc (1998) · Review
Mechanistic model: UV activates MAP-kinase pathways and AP-1, which upregulate matrix metalloproteinases (MMPs)
Daily Use of a Facial Broad Spectrum Sunscreen Over One-Year Significantly Improves Clinical Evaluation of Photoaging.
Dermatol Surg (2016) · Open label · n=32
Single-arm prospective study (n=32): broad-spectrum SPF 30 applied daily to the face for 52 weeks
Sunscreen (SPF) has a higher evidence score (9/10 vs 7/10) and wins in 2 of 3 categories.
For even skin tone, Hydroquinone has a higher relevance score (85 vs 75).
No known interactions between Hydroquinone and Sunscreen (SPF) have been documented in our database. However, always consult a healthcare provider before combining supplements.